HALO logo
halo search icon
Glaukos Corp

US$143.82

Price Change Indicator
3.92 (2.80%)
Glaukos Corp
GKOS · NYS

Glaukos Corp

Start Trading GKOS for Free

US$143.82

Price Arrow3.92 (2.80%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetHALO MomentumHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Glaukos Corp Overview

GKOS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About GKOS

icon
icon

Telephone

1.949.367.9600

icon

Address

One Glaukos Way, Aliso Viejo, CA 92656

Description

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

GKOS Price Chart

Key Stats

Market Cap

US$8.22B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 73.16 - 148.11

Trade Value (12mth)

US$22,950,635.00

1 week

-2.85%

1 month

14.57%

YTD

26.35%

1 year

47.54%

All time high

163.71

Key Fundamentals

EPS 3 yr Growth

57.00%

EBITDA Margin

-8.70%

Operating Cashflow

-$15m

Free Cash Flow Return

-1.80%

ROIC

-23.00%

Interest Coverage

-9.60

Quick Ratio

4.10

Other Data

Shares Outstanding (Fully Diluted)

58m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

GKOS Announcements

Latest Announcements

DateAnnouncements
04 May 26
04 May 26
30 April 26
30 April 26
30 April 26

GKOS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.78-2.77-3.28locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.78-2.77-3.28locklocklock
Growth
 %locklocklocklock-330.2-18.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Glaukos Corp (GKOS:NYS)?
Halo FAQ
The current share price of Glaukos Corp (GKOS:NYS) is USD$143.82.
What is the 52-week high share price for Glaukos Corp (GKOS:NYS)?
Halo FAQ
The 52-week high share price for Glaukos Corp (GKOS:NYS) is USD$148.11.
What is the 52-week low share price for Glaukos Corp (GKOS:NYS)?
Halo FAQ
The 52-week low share price for Glaukos Corp (GKOS:NYS) is USD$73.16.
What is the dividend yield for Glaukos Corp (GKOS:NYS)?
Halo FAQ
Glaukos Corp (GKOS:NYS) does not pay a dividend.
What was Glaukos Corp (GKOS:NYS) last dividend payment?
Halo FAQ
Glaukos Corp (GKOS:NYS) does not pay a dividend.
What is the franking level for Glaukos Corp (GKOS:NYS)?
Halo FAQ
Glaukos Corp (GKOS:NYS) has a franking level of 0.00%.
In which sector is Glaukos Corp (GKOS:NYS) classified?
Halo FAQ
Glaukos Corp (GKOS:NYS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial